These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 8743633

  • 1. Changes in sensitivity to nicotine and brain nicotinic receptors following chronic nicotine and corticosterone treatments in mice.
    Robinson SF, Grun EU, Pauly JR, Collins AC.
    Pharmacol Biochem Behav; 1996 Jul; 54(3):587-93. PubMed ID: 8743633
    [Abstract] [Full Text] [Related]

  • 2. Corticosterone reversibly alters brain alpha-bungarotoxin binding and nicotine sensitivity.
    Grun EU, Pauly JR, Bullock AE, Collins AC.
    Pharmacol Biochem Behav; 1995 Nov; 52(3):629-35. PubMed ID: 8545485
    [Abstract] [Full Text] [Related]

  • 3. Chronic corticosterone administration modulates nicotine sensitivity and brain nicotinic receptor binding in C3H mice.
    Pauly JR, Grün EU, Collins AC.
    Psychopharmacology (Berl); 1990 Nov; 101(3):310-6. PubMed ID: 2362951
    [Abstract] [Full Text] [Related]

  • 4. Tolerance, cross-tolerance, and receptors after chronic nicotine or oxotremorine.
    Marks MJ, Collins AC.
    Pharmacol Biochem Behav; 1985 Feb; 22(2):283-91. PubMed ID: 3983219
    [Abstract] [Full Text] [Related]

  • 5. Species differences in diisopropylfluorophosphate-induced decreases in the number of brain nicotinic receptors.
    Van de Kamp JL, Collins AC.
    Pharmacol Biochem Behav; 1992 May; 42(1):131-41. PubMed ID: 1528936
    [Abstract] [Full Text] [Related]

  • 6. Time course study of the effects of chronic nicotine infusion on drug response and brain receptors.
    Marks MJ, Stitzel JA, Collins AC.
    J Pharmacol Exp Ther; 1985 Dec; 235(3):619-28. PubMed ID: 4078726
    [Abstract] [Full Text] [Related]

  • 7. Regulation of nicotinic receptors in rat brain following quasi-irreversible nicotinic blockade by chlorisondamine and chronic treatment with nicotine.
    el-Bizri H, Clarke PB.
    Br J Pharmacol; 1994 Nov; 113(3):917-25. PubMed ID: 7858886
    [Abstract] [Full Text] [Related]

  • 8. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse.
    Collins AC, Miner LL, Marks MJ.
    Pharmacol Biochem Behav; 1988 May; 30(1):269-78. PubMed ID: 3174752
    [Abstract] [Full Text] [Related]

  • 9. Tolerance to nicotine following chronic treatment by injections: a potential role for corticosterone.
    Pauly JR, Grun EU, Collins AC.
    Psychopharmacology (Berl); 1992 May; 108(1-2):33-9. PubMed ID: 1410144
    [Abstract] [Full Text] [Related]

  • 10. Dissociation of the apparent relationship between nicotine tolerance and up-regulation of nicotinic receptors.
    Collins AC, Romm E, Wehner JM.
    Brain Res Bull; 1990 Sep; 25(3):373-9. PubMed ID: 2292034
    [Abstract] [Full Text] [Related]

  • 11. Chronic corticosterone treatment alters sensory gating in C3H mice.
    Stevens KE, Bullock AE, Collins AC.
    Pharmacol Biochem Behav; 2001 Sep; 69(3-4):359-66. PubMed ID: 11509192
    [Abstract] [Full Text] [Related]

  • 12. Differential expression of the beta4 neuronal nicotinic receptor subunit affects tolerance development and nicotinic binding sites following chronic nicotine treatment.
    Meyers EE, Loetz EC, Marks MJ.
    Pharmacol Biochem Behav; 2015 Mar; 130():1-8. PubMed ID: 25560939
    [Abstract] [Full Text] [Related]

  • 13. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice.
    Sparks JA, Pauly JR.
    Psychopharmacology (Berl); 1999 Jan; 141(2):145-53. PubMed ID: 9952038
    [Abstract] [Full Text] [Related]

  • 14. Dose-response analysis of nicotine tolerance and receptor changes in two inbred mouse strains.
    Marks MJ, Stitzel JA, Collins AC.
    J Pharmacol Exp Ther; 1986 Nov; 239(2):358-64. PubMed ID: 3772799
    [Abstract] [Full Text] [Related]

  • 15. Genotype influences the development of tolerance to nicotine in the mouse.
    Marks MJ, Campbell SM, Romm E, Collins AC.
    J Pharmacol Exp Ther; 1991 Oct; 259(1):392-402. PubMed ID: 1920127
    [Abstract] [Full Text] [Related]

  • 16. Nicotine-induced tolerance and receptor changes in four mouse strains.
    Marks MJ, Romm E, Gaffney DK, Collins AC.
    J Pharmacol Exp Ther; 1986 Jun; 237(3):809-19. PubMed ID: 3712280
    [Abstract] [Full Text] [Related]

  • 17. Deletion of the beta 2 nicotinic acetylcholine receptor subunit alters development of tolerance to nicotine and eliminates receptor upregulation.
    McCallum SE, Collins AC, Paylor R, Marks MJ.
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):314-27. PubMed ID: 16001112
    [Abstract] [Full Text] [Related]

  • 18. Selective changes in sensitivity to cholinergic agonists and receptor changes elicited by continuous physostigmine infusion.
    Bhat RV, Turner SL, Marks MJ, Collins AC.
    J Pharmacol Exp Ther; 1990 Oct; 255(1):187-96. PubMed ID: 2213555
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the development of tolerance to ethanol and cross-tolerance to nicotine after chronic ethanol treatment in long- and short-sleep mice.
    de Fiebre CM, Collins AC.
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1398-406. PubMed ID: 8371145
    [Abstract] [Full Text] [Related]

  • 20. Modulation of nicotine receptors by chronic exposure to nicotinic agonists and antagonists.
    Collins AC, Bhat RV, Pauly JR, Marks MJ.
    Ciba Found Symp; 1990 Sep; 152():68-82; discussion 82-6. PubMed ID: 2209260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.